Sponsor
AIDS Malignancy Consortium
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name AIDS Malignancy Consortium appears in 49 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
49 shownImmune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin LymphomaNCT05077527 · lead sponsor · 2025-02-13
RECRUITINGTrial of Ixazomib for Kaposi SarcomaNCT04305691 · lead sponsor · 2023-11-07
RECRUITINGFeasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan AfricaNCT04704648 · lead sponsor · 2023-06-21
RECRUITINGCollecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related CancersNCT05663502 · lead sponsor · 2023-05-10
RECRUITINGImpact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility StudyNCT04949464 · lead sponsor · 2023-03-22
RECRUITINGA Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaNCT04139304 · lead sponsor · 2021-05-24
RECRUITINGIncidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive MenNCT04142398 · lead sponsor · 2027-04-30
WITHDRAWNIncidence of HIV Infection in Screening Indian Men Who Have Sex With MenNCT04142385 · lead sponsor · 2027-04-30
WITHDRAWNPaclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi SarcomaNCT05411237 · lead sponsor · 2026-09-01
NOT_YET_RECRUITINGUse of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMCNCT05510908 · lead sponsor · 2023-07-25
COMPLETEDTesting the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive WomenNCT03834571 · lead sponsor · 2022-05-31
WITHDRAWNObservational Study of People Living With HIV Treated With CD19-directed CAR T CellNCT05784415 · lead sponsor · 2021-05-22
COMPLETEDPomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus InfectionNCT03601806 · lead sponsor · 2021-04-26
COMPLETEDIncidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin AmericaNCT04089488 · lead sponsor · 2020-01-17
COMPLETEDHPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPVNCT03284866 · lead sponsor · 2019-07-31
COMPLETEDDevelopment of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial LesionsNCT04276935 · lead sponsor · 2018-11-06
COMPLETEDEvaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and VincristineNCT03596918 · lead sponsor · 2018-10-10
COMPLETEDVGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal LesionsNCT03603808 · lead sponsor · 2018-09-21
COMPLETEDIntravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin LymphomaNCT01775475 · lead sponsor · 2016-09-15
COMPLETEDGene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell TransplantNCT02797470 · lead sponsor · 2016-06-23
ACTIVE_NOT_RECRUITINGImiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin LesionsNCT02059499 · lead sponsor · 2015-12-28
COMPLETEDGamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi SarcomaNCT02137564 · lead sponsor · 2015-07-01
WITHDRAWNSurgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV InfectionNCT02437851 · lead sponsor · 2015-04-01
COMPLETEDHealth-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal LesionsNCT02418494 · lead sponsor · 2015-04-01
COMPLETEDTreatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade LesionsNCT02135419 · lead sponsor · 2014-09-24
COMPLETEDCisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical CancerNCT01590017 · lead sponsor · 2014-04-01
COMPLETEDAnal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIVNCT01946139 · lead sponsor · 2013-12-04
COMPLETEDPaclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionNCT01249443 · lead sponsor · 2013-11-01
TERMINATEDFactors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical TrialsNCT01946217 · lead sponsor · 2013-09-01
COMPLETEDCollecting and Studying Tissue Samples From Patients With HIV-Associated MalignanciesNCT01567722 · lead sponsor · 2013-01-02
TERMINATEDVaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With MalesNCT01209325 · lead sponsor · 2011-06-28
COMPLETEDBiomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing ChemotherapyNCT01319526 · lead sponsor · 2011-06-01
TERMINATEDInfrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal NeoplasiaNCT01164722 · lead sponsor · 2011-04-01
COMPLETEDVaccine Therapy in Preventing HPV in HIV-Positive Women in IndiaNCT00667563 · lead sponsor · 2009-08-01
COMPLETEDStudy of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin LymphomaNCT00981097 · lead sponsor · 2009-08-01
COMPLETEDHuman Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With MenNCT00919997 · lead sponsor · 2009-07-01
COMPLETEDPTC299 in Treating Patients With HIV-Related Kaposi SarcomaNCT00686842 · lead sponsor · 2008-09-01
TERMINATEDLiposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's SarcomaNCT00427414 · lead sponsor · 2008-09-01
TERMINATEDDetecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical TrialsNCT00695422 · lead sponsor · 2008-05-14
COMPLETEDSirolimus in Treating Patients With HIV-Related Kaposi's SarcomaNCT00450320 · lead sponsor · 2007-10-01
COMPLETEDCidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the AnusNCT00550589 · lead sponsor · 2007-09-01
COMPLETEDCombined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal CancerNCT00324415 · lead sponsor · 2006-09-01
COMPLETEDRituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's LymphomaNCT00392834 · lead sponsor · 2006-09-01
COMPLETEDImatinib Mesylate in Treating Patients With HIV-Related Kaposi's SarcomaNCT00090987 · lead sponsor · 2005-06-01
COMPLETEDInfrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal NeoplasiaNCT00066430 · lead sponsor · 2003-09-01
COMPLETEDPeripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related LymphomaNCT00024128 · lead sponsor · 2001-08-01
WITHDRAWNChemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related LymphomaNCT00005824 · lead sponsor · 2000-11-01
COMPLETEDZidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System LymphomaNCT00006264 · lead sponsor · 2000-07-01
COMPLETEDHIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXTNCT00380770 · collaborator · 2003-01-01
COMPLETEDSponsor roles
lead sponsor48
collaborator1
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.